AMLX Amylyx Pharmaceuticals, Inc.

NASDAQ
$28.08

Amylyx Pharmaceuticals, Inc. (AMLX) SEC Filings

Everything AMLX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

74 filings
Date Form Filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
144 View filing
144 View filing
144 View filing
144 View filing
144 View filing
8-K Material Agreement View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
8-K Capital Raise · Material Agreement View filing
8-K Investor Presentation · Other Event · Other Reg Fd View filing
8-K Other · Other Event · Other Reg Fd · Reg Fd View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-K View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.